U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
108391108391Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy VolunteersCompletedHas ResultsHealthyDrug: crizotinib|Drug: rifampin|Drug: crizotinibhttps://ClinicalTrials.gov/show/NCT01147055
108392108392Assessment of the Biochemical Response to Interferon-Gamma in Subjects With Specific Gene Mutation in Chronic Granulomatous DiseaseTerminatedNo Results AvailableIFN-Gamma Therapy|CGD Gene Mutation|CGD Response to IFNg|Chronic Granulomatous Disease|Immunodeficiency DiseaseDrug: IFN-gammahttps://ClinicalTrials.gov/show/NCT01147042
108393108393GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to TherapyTerminatedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: angiogenesis inhibitor GSAO|Other: laboratory biomarker analysis|Other: pharmacological study|Procedure: dynamic contrast-enhanced magnetic resonance imaginghttps://ClinicalTrials.gov/show/NCT01147029
108394108394Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing SurgeryRecruitingNo Results AvailableBreast CancerBiological: HER2Bi-armed activated T cells|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: paclitaxel|Other: laboratory biomarker analysis|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgeryhttps://ClinicalTrials.gov/show/NCT01147016
108395108395Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset SeizuresCompletedNo Results AvailablePartial Onset SeizuresDrug: Investigational new drug, company code: BGG492|Drug: Placebo|Drug: Investigational new drug, company code: BGG492https://ClinicalTrials.gov/show/NCT01147003
108396108396A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm BirthRecruitingNo Results AvailableChildren Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy TrialDrug: ASQ-3, Bayley III, Neurologic examhttps://ClinicalTrials.gov/show/NCT01146990
108397108397Autologous Hematopoietic Cell Transplantation for Core-binding Factor (CBF) Acute Myeloid Leukemia (AML) in the First Complete Remission (CR1)RecruitingNo Results AvailableAcute Myeloid LeukemiaOther: HDAC chemotherapy|Other: Autologous HCThttps://ClinicalTrials.gov/show/NCT01146977
108398108398Comparison of Manual Super Small Incision Cataract Surgery and PhacoemulsificationCompletedNo Results AvailableCataract|PhacoemulsificationProcedure: MSSICS|Procedure: Phacoemulsificationhttps://ClinicalTrials.gov/show/NCT01146964
108399108399A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304)CompletedHas ResultsLennox-Gastaut SyndromeDrug: Rufinamide (E2080)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01146951
108400108400A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy VolunteersCompletedNo Results AvailableEssential Hypertension|Hepatic ImpairmentDrug: fimasartan|Drug: fimasartanhttps://ClinicalTrials.gov/show/NCT01146938
108401108401Deferiprone for the Prevention of Contrast-Induced Acute Kidney InjuryCompletedNo Results AvailableContrast-Induced Acute Kidney InjuryDrug: CRMD-001-Deferiprone|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01146925
108402108402TextFluenza: Using Technology To Promote Flu Vaccination In Underserved Maternal And Child PopulationsCompletedHas ResultsInfluenzaOther: Text Message|Other: automated callhttps://ClinicalTrials.gov/show/NCT01146912
108403108403FluAlert: Influenza Vaccine Alerts for Providers in the Electronic Health RecordCompletedNo Results AvailableInfluenzaOther: Provider Alerthttps://ClinicalTrials.gov/show/NCT01146899
108404108404Trial to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI135585 XX Administered as Tablet and as Solution in Healthy VolunteersCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Placebo to BI 135585|Drug: BI 135585https://ClinicalTrials.gov/show/NCT01146886
108405108405Treatment Options for Protease Inhibitor-exposed ChildrenCompletedNo Results AvailableHIV/AIDS|HIV InfectionsDrug: Efavirenz|Drug: Lopinavir/ritonavir (LPV/r)|Drug: D4T|Drug: Abacavir (ABC)https://ClinicalTrials.gov/show/NCT01146873
108406108406Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute RhinosinusitisCompletedHas ResultsAcute RhinosinusitisDrug: BNO 1016|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01146860
108407108407Feasibility of Tight Blood Glucose Control With the Space TGC System in Surgical ICU PatientsCompletedNo Results AvailableCritical IllnessDevice: Space TGChttps://ClinicalTrials.gov/show/NCT01146847
108408108408Trial of Three Stem Cell Mobilization Regimens for Multiple MyelomaRecruitingNo Results AvailableMultiple MyelomaDrug: bortezomib (Velcade)|Drug: cyclophosphamide|Drug: G-CSFhttps://ClinicalTrials.gov/show/NCT01146834
108409108409Fish OIL Optimal dosE Determination StudyRecruitingNo Results AvailableSepsisDietary Supplement: 0.20 gm/kg fish oil|Dietary Supplement: 0.50 gm/kg fish oilhttps://ClinicalTrials.gov/show/NCT01146821
108410108410Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive LiverActive, not recruitingNo Results AvailableHepatitis B|Liver TransplantationDrug: Adefovir dipivoxil and hepatitis B vaccinationhttps://ClinicalTrials.gov/show/NCT01146808
108411108411Neoadjuvant Therapy for Ovarian CancerRecruitingNo Results AvailableEpithelial Ovarian Cancer|Primary Peritoneal Cancer|Fallopian Tube CancerDrug: Carboplatin, paclitaxel, and bevacizumabhttps://ClinicalTrials.gov/show/NCT01146795
108412108412Study of a Sleep Apnea System for the Treatment of Obstructive Sleep ApneaCompletedHas ResultsObstructive Sleep ApneaDevice: Attune Sleep Apnea Systemhttps://ClinicalTrials.gov/show/NCT01146782
108413108413Early Pelvic Floor Muscle Training Improves Pelvic Floor Muscle Strength in Patient After Low Anterior ResectionRecruitingNo Results AvailableCancer of RectumOther: Pelvic floor exercisehttps://ClinicalTrials.gov/show/NCT01146769
108414108414MEK Inhibitor and Thoracic Radiotherapy TrialRecruitingNo Results AvailableNon Small Cell Lung CancerDrug: AZD6244https://ClinicalTrials.gov/show/NCT01146756
108415108415Prospective Trial for Endoscopic Ultrasound Guided Gallbladder Drainage for Acute Cholecystitis in High Risk PatientsCompletedNo Results AvailableCholecystitisProcedure: EUS-guided gallbladder drainage|Procedure: percutaneous transhepatic gallbladder drainagehttps://ClinicalTrials.gov/show/NCT01146743
108416108416At Work and Coping - Effect Study of Workcoping for Patients With Anxiety and DepressionActive, not recruitingNo Results AvailableAnxiety|DepressionBehavioral: Workcoping and IPS|Behavioral: Ordinary care by GP or NAVhttps://ClinicalTrials.gov/show/NCT01146730
108417108417Aerobic Exercise Training in Mild Cognitive Impairment StudyActive, not recruitingNo Results AvailableMild Cognitive ImpairmentBehavioral: Exercise|Behavioral: Balance traininghttps://ClinicalTrials.gov/show/NCT01146717
108418108418Gastrointestinal Hormonal Regulation of ObesityRecruitingNo Results AvailableObesityDietary Supplement: Protein powder supplement, standard dosage based on 0.5 gram protein per pound of subject's lean body mass|Dietary Supplement: Protein powder supplement, High Level Protein, based on 1 gram of protein per pound of lean body mass: 25% protein and 45% carbohydrate|Dietary Supplement: Very high protein diet group based on 1.4 gram of protein per pound of subject's lean body mass: 35% protein and 35% carbohydrate.https://ClinicalTrials.gov/show/NCT01146704
108419108419Effect of Around the Clock Intensivist Coverage on Intensive Care Unit (ICU) OutcomesCompletedNo Results AvailableCritical Illness|Burnout, Professional|Education, Medical|Patient SatisfactionOther: Alternative Intensivist staffing modelshttps://ClinicalTrials.gov/show/NCT01146691
108420108420Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1CompletedNo Results AvailableType 1 Diabetes MellitusDrug: Insulin glargine HOE901|Drug: Lixisenatide AVE0010https://ClinicalTrials.gov/show/NCT01146678

* Görseller ve İçerik tekif hakkına sahip olabilir